Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

Berenberg lowers target price on Baltic Classifieds

(Sharecast News) - Analysts at Berenberg lowered their target price on Baltic Classifieds from 395p to 360p on Thursday following the group's "very brief and unscheduled" AGM trading statement on 24 September. Baltic Classifieds pointed to continued weakness in the Estonian car market and, as a result, revised its full-year outlook. Baltic Classifieds now expects revenue and profit growth for the full year to be 3-4% below its previous expectations.

"We revise our numbers to reflect this revised guidance, effectively reducing our FY26 revenue and profit estimates by 4%. We also adjust our share buyback assumptions accordingly. We understand that the other divisions continue to trade as expected. This means that we expect growth to fall short of management's target of 15% annual revenue growth set out by the company at its IPO," said Berenberg.

"We maintain our growth assumptions in outer years, prudently assuming that the Estonia car tax is not repealed and that trading volumes remain at lower levels due to the increased cost of business."

The German bank said the stock now trades on a FY26 price-to-earnings ratio of 27.0x and an FY26E free cash flow yield of 4.0%. Berenberg added that it continues to value Baltic Classifieds using a discounted cash flow and P/E multiples approach.

"The stock is now trading at a discount to its two-year historical average of 33x FY1 P/E, which we think is an attractive entry point to what remains a compelling investment case," added Berenberg, which reiterated its 'buy' rating on the stock.

Reporting by Iain Gilbert at Sharecast.com

Share this article

Related Sharecast Articles

GSK gets preliminary nod for two respiratory drugs in Europe
(Sharecast News) - GSK said on Friday afternoon that two of its respiratory medicines had received positive opinions from the European Medicines Agency's Committee for Medicinal Products for Human Use, bringing the company closer to potential approvals across severe asthma, chronic rhinosinusitis with nasal polyps and chronic obstructive pulmonary disease.
Shore Capital hails improved US biotech funding environment for hVIVO
(Sharecast News) - Shares in AIM-listed hVIVO were continuing their recent surge on the back of encouraging signs from the US biotech market, which broker Shore Capital said has created a "much more favourable environment" for the company.
Weir to buy remaining 50% stake in Chile JV ESEL for £56m
(Sharecast News) - Weir said on Friday that it has agreed to buy the remaining 50% share of its Chile-based joint venture ESEL for a sterling equivalent purchase price of £56m.
Jefferies downgrades Whitbread, upgrades IHG
(Sharecast News) - Jefferies downgraded Whitbread to 'hold' from 'buy' on Friday as it applied the reverse upgrade to InterContinental Hotels.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.